Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

医学 外科 养生 随机对照试验 癌 食管切除术 放化疗 放射治疗 食管癌 长春碱 食管 化疗 内科学 癌症
作者
Susan G. Urba,Mark B. Orringer,Andrew T. Turrisi,Mark D. Iannettoni,Arlene A. Forastiere,Myla Strawderman
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:19 (2): 305-313 被引量:1316
标识
DOI:10.1200/jco.2001.19.2.305
摘要

PURPOSE: A pilot study of 43 patients with potentially resectable esophageal carcinoma treated with an intensive regimen of preoperative chemoradiation with cisplatin, fluorouracil, and vinblastine before surgery showed a median survival of 29 months in comparison with the 12-month median survival of 100 historical controls treated with surgery alone at the same institution. We designed a randomized trial to compare survival for patients treated with this preoperative chemoradiation regimen versus surgery alone. MATERIALS AND METHODS: One hundred patients with esophageal carcinoma were randomized to receive either surgery alone (arm I) or preoperative chemoradiation (arm II) with cisplatin 20 mg/m2/d on days 1 through 5 and 17 through 21, fluorouracil 300 mg/m2/d on days 1 through 21, and vinblastine 1 mg/m2/d on days 1 through 4 and 17 through 20. Radiotherapy consisted of 1.5-Gy fractions twice daily, Monday through Friday over 21 days, to a total dose of 45 Gy. Transhiatal esophagectomy with a cervical esophagogastric anastomosis was performed on approximately day 42. RESULTS: At median follow-up of 8.2 years, there is no significant difference in survival between the treatment arms. Median survival is 17.6 months in arm I and 16.9 months in arm II. Survival at 3 years was 16% in arm I and 30% in arm II (P = .15). This study was statistically powered to detect a relatively large increase in median survival from 1 year to 2.2 years, with at least 80% power. CONCLUSION: This randomized trial of preoperative chemoradiation versus surgery alone for patients with potentially resectable esophageal carcinoma did not demonstrate a statistically significant survival difference.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wananaikedai完成签到,获得积分10
1秒前
张123完成签到,获得积分10
1秒前
2秒前
湘湘完成签到,获得积分10
2秒前
bybyca完成签到,获得积分10
2秒前
科研通AI6.4的应助被林鹿采纳,获得10
2秒前
nan11完成签到,获得积分10
3秒前
桐桐的应助被曾经又柔采纳,获得10
3秒前
3秒前
4秒前
一安完成签到,获得积分10
5秒前
Medici完成签到,获得积分10
6秒前
19978923839完成签到,获得积分10
6秒前
萝卜大王完成签到,获得积分20
6秒前
6秒前
艾叶发布了新的文献求助10
7秒前
7秒前
7秒前
7秒前
8秒前
风趣之云完成签到 ,获得积分10
8秒前
jja881完成签到,获得积分10
9秒前
九司完成签到,获得积分10
9秒前
Xk发布了新的文献求助10
9秒前
10秒前
zhumeili完成签到,获得积分10
11秒前
未白发布了新的文献求助10
11秒前
misscloud发布了新的文献求助10
11秒前
人间慈悲的应助被西西采纳,获得10
11秒前
cz完成签到 ,获得积分10
12秒前
12秒前
123131发布了新的文献求助10
12秒前
14秒前
lindollar发布了新的文献求助10
14秒前
搞怪的老九的应助被小吴采纳,获得20
14秒前
zhumeili发布了新的文献求助10
14秒前
15秒前
September完成签到 ,获得积分10
15秒前
独特振家完成签到,获得积分10
15秒前
Edward完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187226
求助须知:如何正确求助?哪些是违规求助? 9575395
关于积分的说明 21841040
捐赠科研通 7784958
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559355
邀请新用户注册赠送积分活动 2481808